Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

FFR-guided percutaneous coronary intervention provides cost-saving benefits

St. Jude Medical, Inc., a global medical device company, today announced the publication of results from an economic evaluation of the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) trial, which confirmed FFR-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease improves patient outcomes and offers cost-saving benefits to the U.S. healthcare system.

17 Dec 2010

Viron's Phase 2a trial for VT-111 meets primary, secondary endpoints in ACS patients

Viron Therapeutics Inc. today announced that the results of Viron's Phase 2a trial for VT-111 were published today in Circulation: Cardiovascular Interventions. In the study led by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, VT-111, also known as Serp-1, met both its primary and secondary endpoints of safety and biological activity in Acute Coronary Syndrome patients receiving coronary stents.

17 Dec 2010

Zogenix's SUMAVEL DosePro Needle-free Delivery System wins 2010 Most Innovative Product award

Zogenix, Inc. today announced that CONNECT, a regional San Diego nonprofit organization, selected SUMAVEL® DosePro™ (sumatriptan injection) Needle-free Delivery System as a 2010 Most Innovative Product (MIP) winner at the MIP Awards Luncheon on December 10, 2010.

13 Dec 2010

U-M's participation in Medicare Physician Group Practice Demonstration Project helps save over $15 million

Medicare patients with a host of physical problems are getting better care at the University of Michigan Health System, and U-M staff have saved more than $15 million on the cost of that care over four years.

13 Dec 2010

Chinese study examines association between alcohol intake, CAD

Among a large number of Chinese men presenting with chest pain or EKG changes, sequential subjects undergoing cardiac angiography were evaluated for obstructive coronary artery disease lesions according to their reported recent alcohol intake. The study population consisted of 1,476 consecutive men 36 to 84 years of age; participants were categorized as nondrinkers, light drinkers, moderate drinkers, or heavy drinkers.

10 Dec 2010

Acorda initiates enrollment in GGF2 Phase 1 clinical trial in patients with heart failure

Acorda Therapeutics, Inc. today announced that the first patient has been enrolled in the first clinical trial of Glial Growth Factor 2 (GGF2). Acorda is collaborating with the Vanderbilt University Heart and Vascular Institute to conduct this Phase 1 single-dose trial in patients with heart failure.

9 Dec 2010

Detection of blood biomarker cTnT associated with structural heart disease

With the use of a highly sensitive test, detection of the blood biomarker cardiac troponin T, a cardiac-specific protein, is associated with structural heart disease and an increased risk of all-cause death, according to a study in the December 8 issue of JAMA.

8 Dec 2010

New sensitive blood test could determine unrecognized heart disease

A more sensitive version of a blood test typically used to confirm that someone is having a heart attack could indicate whether a seemingly healthy, middle-aged person has unrecognized heart disease and an increased risk of dying, UT Southwestern Medical Center researchers have found.

7 Dec 2010

Sheathless transradial intervention highly successful in treating complex lesions

Cardiologists from the Mayo Clinic performed sheathless transradial percutaneous coronary intervention (PCI) to remedy complex lesions, achieving a 90% success rate with no radial complications. Standard guiding catheters were used during the procedure. Details of this novel approach—overcoming the last hurdle to greater adoption of transradial PCI in the U.S.—are published in the December issue of Catheterization and Cardiovascular Intervention, the official journal of The Society for Cardiovascular Angiography and Interventions.

7 Dec 2010

Stereotaxis awarded VA Federal Supply Schedule Contract for Niobe Remote Magnetic Navigation System

Stereotaxis, Inc. announced that the United States Department of Veteran Affairs awarded Stereotaxis a Federal Supply Schedule Contract for its Niobe® Remote Magnetic Navigation System, related service agreement, and disposable products. This contract, effective December 15, 2010, is for five years, with a five year renewal option.

7 Dec 2010

Rcadia's COR Analyzer System effective to rule-out coronary artery disease

Physicians at Thomas Jefferson University Hospital reported today on results of a study demonstrating the potential for fully automated interpretation of coronary CT angiography (cCTA) by Rcadia's COR Analyzer® System to safely rule out coronary artery disease (CAD) in the major coronary arteries as well as branch vessels.

3 Dec 2010

FDA approves IDE application to initiate Tryton Side Branch Stent System for coronary artery disease

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced U.S. Food and Drug Administration (FDA) conditional approval for an Investigational Device Exemption (IDE) application to initiate the pivotal trial to evaluate the Tryton Side Branch Stent System for the treatment of coronary artery disease.

2 Dec 2010

Denmark grants marketing authorization for SUMAVEL DosePro Needle-Free Delivery System

Zogenix, Inc. and Desitin Pharmaceuticals GmbH today announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application (MAA) for SUMAVEL® DosePro™ (sumatriptan injection) Needle-Free Delivery System. Denmark is the first country in Europe to grant marketing authorization for SUMAVEL DosePro for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache.

2 Dec 2010

Nine out of ten of all primary care centers in Sweden prescribe physical activity

Prescribing physical activity for the purpose of preventing and treating various conditions can now become a reality for healthcare professionals all over the world.

30 Nov 2010

Study confirms difference in coronary artery disease pathways among Caucasians, African Americans

In a study being presented today at the annual meeting of the Radiological Society of North America (RSNA), researchers say they may have an explanation as to why African Americans, despite having lower amounts of coronary artery calcification, are at increased risk for heart attacks and other cardiovascular events compared with Caucasians.

30 Nov 2010

Siemens to distribute Rcadia's COR Analyzer System

Rcadia Medical Imaging and Siemens Healthcare have entered into an agreement for Siemens to distribute Rcadia's COR Analyzer® System. The COR Analyzer's ability to identify stenotic lesions in Coronary Computed Tomography Angiography (cCTA) studies in combination with Siemens' Syngo®.via CT Cardio-Vascular Engine provides a comprehensive solution for evaluating suspected cardiac patients. The integration of both systems realizes a seamless workflow with enhanced productivity.

30 Nov 2010

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).

29 Nov 2010

Study reports increased CT usage in emergency departments

A new study reports that the use of computed tomography (CT) in the nation's emergency departments is growing exponentially. If the growth trend continues, by 2011, nearly 20 percent of all emergency department (ED) visits may involve a CT exam. The results of this study were presented today at the annual meeting of the Radiological Society of North America (RSNA) and published online and in the journal Radiology.

29 Nov 2010

More salt in many holiday meals, cardiologist warns

There can be far more salt in many holiday meals than people realize, and the proof can be found at hospital emergency rooms. Heart problems aggravated or unmasked after ingestion of a significant amount of salt tend to make holidays such as Thanksgiving, Passover and Christmas very busy times for health providers like University of Medicine and Dentistry of New Jersey (UMDNJ) cardiologist Marc Klapholz, M.D., F.A.C.C.

24 Nov 2010

Cardiac stem cells from sick patients could generate new heart muscle: Research

Cardiac stem cells even in elderly and sick patients could generate new heart muscle and vessel tissue and be used to treat heart failure, according to research presented at the American Heart Association's Scientific Sessions 2010.

18 Nov 2010

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

FFR-guided percutaneous coronary intervention provides cost-saving benefits

Viron's Phase 2a trial for VT-111 meets primary, secondary endpoints in ACS patients

Zogenix's SUMAVEL DosePro Needle-free Delivery System wins 2010 Most Innovative Product award

U-M's participation in Medicare Physician Group Practice Demonstration Project helps save over $15 million

Chinese study examines association between alcohol intake, CAD

Acorda initiates enrollment in GGF2 Phase 1 clinical trial in patients with heart failure

Detection of blood biomarker cTnT associated with structural heart disease

New sensitive blood test could determine unrecognized heart disease

Sheathless transradial intervention highly successful in treating complex lesions

Stereotaxis awarded VA Federal Supply Schedule Contract for Niobe Remote Magnetic Navigation System

Rcadia's COR Analyzer System effective to rule-out coronary artery disease

FDA approves IDE application to initiate Tryton Side Branch Stent System for coronary artery disease

Denmark grants marketing authorization for SUMAVEL DosePro Needle-Free Delivery System

Nine out of ten of all primary care centers in Sweden prescribe physical activity

Study confirms difference in coronary artery disease pathways among Caucasians, African Americans

Siemens to distribute Rcadia's COR Analyzer System

Micell initiates enrollment in DESSOLVE I clinical trial of MiStent DES

Study reports increased CT usage in emergency departments

More salt in many holiday meals, cardiologist warns

Cardiac stem cells from sick patients could generate new heart muscle: Research

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Newsletters you may be interested in